(Q43832742)

27 November 2017

Selective urokinase-type plasminogen activator (uPA) inhibitors. Part 1: 2-Pyridinylguanidines (English)

1 reference

27 November 2017

Christopher G Barber

1

1 reference

27 November 2017

Roger P Dickinson

series ordinal

2

1 reference

27 November 2017

Valerie A Horne

series ordinal

3

1 reference

27 November 2017

language of work or name

English

0 references

publication date

1 January 2002

1 reference

Bioorganic & Medicinal Chemistry Letters

27 November 2017

1 reference

27 November 2017

12

1 reference

27 November 2017

2

1 reference

27 November 2017

181-184

1 reference

Urokinase-type plasminogen activator and its receptor: new targets for anti-metastatic therapy?

27 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900701-6

7 January 2021

Tissue and urokinase plasminogen activators in the environs of venous and ischaemic leg ulcers

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900701-6

7 January 2021

Proteolytic activity in leg ulcer exudate

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900701-6

7 January 2021

Involvement of proteolytic enzymes--plasminogen activators and matrix metalloproteinases--in the pathophysiology of pressure ulcers.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900701-6

7 January 2021

Temporal expression of urokinase plasminogen activator, plasminogen activator inhibitor and gelatinase-B in chronic wound fluid switches from a chronic to acute wound profile with progression to healing

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900701-6

7 January 2021

Amidino-substituted aromatic heterocycles as probes of the specificity pocket of trypsin-like proteases

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900701-6

7 January 2021

Inhibitory effect of amidino-substituted heterocyclic compounds on the amidase activity of plasmin and of high and low molecular weight urokinase and on urokinase-induced plasminogen activation

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900701-6

7 January 2021

The synthesis of three 4-substituted benzo[b]thiophene-2-carboxamidines as potent and selective inhibitors of urokinase

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900701-6

7 January 2021

Amiloride selectively inhibits the urokinase-type plasminogen activator

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900701-6

7 January 2021

Selective inhibition of urokinase by substituted phenylguanidines: quantitative structure-activity relationship analyses

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900701-6

7 January 2021

Structure-directed discovery of potent non-peptidic inhibitors of human urokinase that access a novel binding subsite.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900701-6

7 January 2021

3-Amidinophenylalanine-based inhibitors of urokinase

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900701-6

7 January 2021

(4-aminomethyl)phenylguanidine derivatives as nonpeptidic highly selective inhibitors of human urokinase

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900701-6

7 January 2021

Re-engineering of human urokinase provides a system for structure-based drug design at high resolution and reveals a novel structural subsite

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900701-6

7 January 2021

The crystal structure of the catalytic domain of human urokinase-type plasminogen activator

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900701-6

7 January 2021

10.1016/S0960-894X(01)00701-6

Identifiers

DOI

1 reference

27 November 2017

1 reference